Beginning July 6, both traditional Medicare and Medicare Advantage plans will cover diagnostic COVID-19 laboratory tests for nursing home residents and patients through the remainder of the public health emergency, the Centers for Medicare & Medicaid Services announced Friday.

The Centers for Disease Control and Prevention recently recommended testing all nursing home residents and patients with COVID-19 symptoms or potential exposure. MA plans must continue not to charge cost sharing (including deductibles, copayments and coinsurance) or apply prior authorization or other utilization management requirements for COVID-19 tests and testing-related services, CMS notes.

Related News Articles

Headline
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nunc bibendum dolor lectus, vitae vehicula quam condimentum vitae. Fusce vel nibh eu urna dictum…
Headline
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nunc bibendum dolor lectus, vitae vehicula quam condimentum vitae. Fusce vel nibh eu urna dictum…
Headline
Ellume has expanded its recall of rapid at-home COVID-19 antigen tests to about 2 million tests, the Food and Drug Administration said in an update this week.…
Headline
The Centers for Disease Control and Prevention’s National Institute for Occupational Safety and Health will host a virtual panel discussion Nov. 18 at 2:30 p.m…
Headline
The Centers for Medicare & Medicaid Services today repealed a final rule codifying how it defines “reasonable and necessary” coverage for items and…
Headline
The Centers for Medicare & Medicaid Services today released final guidance on hospital co-location with other hospitals or health care facilities. Proposed…